1. Home
  2. BHVN vs FRME Comparison

BHVN vs FRME Comparison

Compare BHVN & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • FRME
  • Stock Information
  • Founded
  • BHVN 2013
  • FRME 1893
  • Country
  • BHVN United States
  • FRME United States
  • Employees
  • BHVN N/A
  • FRME N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • FRME Major Banks
  • Sector
  • BHVN Health Care
  • FRME Finance
  • Exchange
  • BHVN Nasdaq
  • FRME Nasdaq
  • Market Cap
  • BHVN 1.9B
  • FRME 2.1B
  • IPO Year
  • BHVN 2017
  • FRME N/A
  • Fundamental
  • Price
  • BHVN $14.63
  • FRME $40.74
  • Analyst Decision
  • BHVN Strong Buy
  • FRME Buy
  • Analyst Count
  • BHVN 14
  • FRME 4
  • Target Price
  • BHVN $58.85
  • FRME $44.75
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • FRME 358.4K
  • Earning Date
  • BHVN 08-07-2025
  • FRME 07-23-2025
  • Dividend Yield
  • BHVN N/A
  • FRME 3.53%
  • EPS Growth
  • BHVN N/A
  • FRME 2.61
  • EPS
  • BHVN N/A
  • FRME 3.55
  • Revenue
  • BHVN N/A
  • FRME $615,411,000.00
  • Revenue This Year
  • BHVN $3.00
  • FRME $15.14
  • Revenue Next Year
  • BHVN $59.97
  • FRME $5.03
  • P/E Ratio
  • BHVN N/A
  • FRME $11.47
  • Revenue Growth
  • BHVN N/A
  • FRME N/A
  • 52 Week Low
  • BHVN $13.87
  • FRME $32.28
  • 52 Week High
  • BHVN $55.70
  • FRME $46.13
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.97
  • FRME 70.16
  • Support Level
  • BHVN $14.00
  • FRME $37.65
  • Resistance Level
  • BHVN $15.09
  • FRME $37.82
  • Average True Range (ATR)
  • BHVN 0.73
  • FRME 1.31
  • MACD
  • BHVN 0.13
  • FRME 0.48
  • Stochastic Oscillator
  • BHVN 41.44
  • FRME 94.15

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: